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Radiation therapy for head and neck cancer frequently causes salivary gland dysfunction.
Pilocarpine is a clinically approved and effective drug that induces saliva secretion, thereby
keeping the oral mucosa moist and reducing discomfort in patients, but the effect is
transient. We expected that this drug also has beneficial long-term effects that maintain the
integrity of salivary glands by reducing, for instance, apoptosis. Here, we examined the
effects of long-term pilocarpine administration in irradiated mice. The results indicated that
long-term pilocarpine administration significantly improved salivary flow in irradiated mice,
suggesting the potential beneficial effects of long-term administration. To elucidate the
underlying mechanism, we analyzed the histology, apoptosis, and proliferation of acinar
cells, and the expression of functional membrane proteins such as transmembrane member
16A, aquaporin-5, and Na-K-Cl cotransporter. Long-term pilocarpine treatment seemed to
decrease irradiation-induced apoptosis, although the change was not statistically significant.
The present results indicated that long-term administration of pilocarpine has beneficial
effects on salivary flow in irradiated mice, and suggested that long-term administration
possibly decreases apoptosis in irradiated salivary glands.
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I. Introduction
Radiation therapy is frequently used for head and
neck cancer treatment [5, 32]. However, damage to healthy
salivary glands often induces xerostomia (dry mouth) [24].
Patients with xerostomia have uncomfortable symptoms
such as oral discomfort or pain, resulting in difficulties in
eating, speaking, and swallowing, and increased risk of
dental caries or oral infection [9, 12]. These conditions may
lead to depression and a decline in quality of life [6]; there‐
fore, effective therapies are needed. Pilocarpine is clinically
used for relieving xerostomia symptoms [16, 27, 40].
Pilocarpine is a muscarinic cholinergic agonist that stimu‐
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lates transient salivary secretion [1, 11, 33]. Stimulation of
the muscarinic-3 acetylcholine receptor (M3 receptor) by
cholinergic agents such as pilocarpine activates transmem‐
brane member 16A (TMEM16A) on the apical membrane
of acinar cells in a calcium-dependent manner, inducing the
secretion of Cl− into the lumen [4, 34]. Along with Cl−
secretion, Na+ moves through the paracellular pathway to
the acinar lumen, resulting in water secretion through
aquaporin-5 (AQP5) on the apical membrane [25, 28] and
through the paracellular pathway [30]. At the same time,
Cl− is supplied by the Na-K-Cl cotransporter (NKCC1) on
the basolateral membrane of acinar cells [10]. Pilocarpine
is prescribed for its acute and short-term effect on inducing
salivary fluid secretion. Long-term pilocarpine administra‐
tion in patients with radiation therapy-induced xerostomia
is effective for restoring salivary flow and relieving symp‐
toms [16, 27, 40]. This suggests that, in addition to its tran‐
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sient effect on stimulating salivary secretion, pilocarpine
has long-lasting beneficial activity against irradiation-
induced salivary gland dysfunction. The underlying
mechanism of this potential beneficial effect, however, is
not understood. The aim of the present study was to investi‐
gate the underlying mechanism as well as to ascertain
the beneficial effect of long-term pilocarpine treatment
using an animal model. Coppes et al. [8] examined the
effect of one-time administration of pilocarpine before
irradiation with 15 gray (Gy) on salivary flow in rats, and
the results showed that salivary flow improved for up to 60
days compared with that in untreated irradiated animals.
As long-term pilocarpine administration in patients with
radiation therapy-induced xerostomia is reported to effec‐
tive for salivary flow and relieving symptoms [16, 27, 40],
daily administration of pilocarpine in irradiated animals
was expected to more effectively ameliorate salivary flow
than one-time administration of pilocarpine over 60 days.
Moreover, the effective prevention from salivary gland
dysfunction induced by irradiation was expected to facili‐
tate the analysis of the underlying mechanism. In the
present study, therefore, we examined the effect of daily
administration of pilocarpine from 5 days before to 63
days after irradiation on salivary flow. Then the underlying
mechanism was investigated by measuring apoptosis,
cellular proliferation, and the expression of the functional
membrane proteins TMEM16A, AQP5, and NKCC1.
II. Materials and Methods
Animals
Similar to previous studies [2, 22, 23, 26, 31, 37, 39],
female animals were used in this study. Nine-week-old
(body weight, 30–32 g) female ICR mice were purchased
from SLC Inc. (Shizuoka, Japan). All animal experiments
were performed in compliance with the NIH Guide for the
Care and Use of Laboratory Animals and approved by the
Animal Care and Experimentation Committee, Gunma
University, Showa Campus (approval no. 17-026). Mice
were maintained using normal chow and water during the
experiment.
Thirty mice were randomly divided into three groups
(Fig. 1).
1) Control group: CTR; untreated (n = 10).
2) Irradiated group: IRD; irradiated without pilocar‐
pine administration (n = 10).
3) Irradiated and pilocarpine-treated group: IRD+Pilo;
irradiated and treated with pilocarpine daily from 5 days
before to 63 days after irradiation (n = 10). Pilocarpine
hydrochloride (Sigma-Aldrich P6503, St Louis, MO, USA)
was diluted to 0.25 mg/ml in physiological saline (Otsuka
Pharmaceutical, Tokyo, Japan), and 0.1 ml was orally
administered with a Teflon tube under isoflurane anesthe‐
sia. The dose of pilocarpine used in this study was deter‐
mined as follows. Considering that patients usually receive
5 mg of pilocarpine hydrochloride three times a day and
assuming a patient’s weight of 60 kg, the dose will be 8.3
μg/100 g. Considering that the weight of mice at the start of
the experiment was approximately 30 g, the dose should be
2.5 μg. In the present study, mice were treated with a 10-
fold higher dose of 25 μg twice a day, morning and night.
Irradiation
Before irradiation, mice were anesthetized with an
intraperitoneal injection of 10 mg/100 g of body weight
(bw) ketamine and 1 mg/100 g of bw xylazine. A 20 × 30
mm window was opened on a 1 mm thick lead plate, and
only the area including the submandibular and parotid
glands was exposed. Irradiation with a single dose of 15 Gy
was delivered using an X-ray unit (Faxitron MultiRad 225;
Acrobio, Tokyo, Japan).
Measurement of stimulated salivary flow
The amount of saliva secreted from all salivary glands
after stimulation with pilocarpine was measured at 30 and
63 days after irradiation. Oral administration of pilocarpine
to IRD+Pilo animals was omitted on the day of measuring
salivary flow. All mice were weighed and anesthetized by
an intraperitoneal injection of 10 mg/100 g of bw ketamine
and 1 mg/100 g of bw xylazine. After anesthesia, 0.5 mg/kg
of bw pilocarpine was injected subcutaneously to induce
salivary secretion. Total saliva was collected from the
mouth and transferred to a 5 ml micro-tube connected to a
polyethylene tube and an aspirator (VACUSIP; Integra
Biosciences, Hudson, NH, USA) for 10 min after pilo‐
carpine injection. The amount of saliva per body weight
was calculated and statistically analyzed.
Tissue sampling
Animals were sacrificed and tissues were collected
at 65 days after irradiation as follows: for histochemical
analyses, four randomly chosen mice from each group
were deeply anesthetized with 10 mg/100 g of bw ketamine
Animal groups and administration procedure. Animals were
divided into three groups. CTR: control group. IRD: irradiated group.
IRD+Pilo: irradiated and pilocarpine-administered group. Pilocarpine
administration was initiated 5 days before irradiation. Salivary flow
was measured at 30 and 63 days after irradiation. Tissue sampling was
performed at 65 days after irradiation.
Fig. 1. 
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and 1 mg/100 g of bw xylazine, and perfused with 4%
paraformaldehyde in 0.1 M phosphate buffer (pH 7.4)
following physiological saline (Otsuka Pharmaceutical).
Whole parotid and submandibular gland tissues were
excised and incubated in the same fixative overnight.
After washing with PBS, tissue blocks were dehydrated
through a series of graded ethanol, cleared in xylene, and
embedded in paraffin.
Hematoxylin-eosin staining
Paraffin sections of 4 μm thickness were cut and
mounted on adhesive glass slides (Platinum; Matsunami,
Osaka, Japan). Sections were deparaffinized with xylene,
rehydrated, and washed with PBS. Sections were stained
with Mayer’s hematoxylin (30002; Muto Pure Chemicals,
Tokyo, Japan) and eosin (32002; Muto Pure Chemicals),
and observed under an AxioPhoto2 microscope (Zeiss,
Overkochen, Germany). Images were captured using a
DP72 digital camera (Olympus, Tokyo, Japan) and
CellSens standard software (Olympus).
Antibodies and specificity
Rabbit anti-AQP5 (AffRaTM14) and guinea pig anti-
AQP5 (AffGPTM41) were developed and characterized in
our laboratory [29, 28]. Rabbit anti-cleaved caspase-3
(Asp175) (9661; Cell Signaling, Beverly, MA, USA) [35],
rabbit anti-Ki67 (ab16667; Abcam, Cambridge, MA,
USA), rabbit anti-NKCC1 (ab59791; Abcam), and rabbit
anti-TMEM16A (ab53212; Abcam) were purchased as
indicated. Secondary antibodies used were HRP-conjugated
goat anti-rabbit (P0448; DAKO, Glostrup, Denmark),
Rhodamine Red-X-conjugated donkey anti-rabbit (711-
295-152; Jackson ImmunoResearch, West Grove, PA, USA),
Alexa 488-conjugated donkey anti-rabbit (A21206; Life
Technologies), and Alexa 488-conjugated donkey anti-
guinea pig antibodies, which were made by conjugating
Alexa 488 to donkey anti-guinea pig IgG (706-005-148;
Jackson ImmunoResearch) by our laboratory using Alexa
488 protein labeling kit (A10235; Life Technologies). The
specificities of commercial antibodies against cleaved
caspase-3, Ki67, TMEM16A, and NKCC1 were confirmed
by immunoblotting and immunofluorescence as described
below.
Antibody to cleaved caspase-3
HeLa cells were cultured on plastic dishes for immu‐
noblotting or on collagen-coated coverslips for immuno‐
fluorescence, and then treated with 30 μM cisplatin to
induce apoptosis [15, 20, 41] or vehicle (Dulbecco’s PBS)
for 13 hr at 37°C.
For immunoblotting, cells were scraped in PBS and
centrifuged, and the pellet was homogenized in PBS con‐
taining a protease inhibitor (Complete Mini; Roche Applied
Science, Mannheim, Germany). Samples were denatured
by boiling for 3 min in an equal volume of buffer con‐
taining 50 mM Tris-HCl (pH 7.5), 4% SDS, 300 mM
dithiothreitol, 50% glycerol, and 0.01% bromophenol
blue. Proteins were separated by SDS-PAGE in a 5–20%
polyacrylamide gel (EHR T520L; ATTO, Tokyo, Japan),
and transferred to a polyvinylidene difluoride membrane
(Immobilon-PSQ; Merck Millipore, Billerica, MA, USA).
MagicMark XP western protein standard (LC5602; Life
Technologies, Grand Island, NY, USA) and Novex sharp
pre-stained protein standard (LC5800; Life Technologies)
were used as the molecular weight standards. After block‐
ing with StartingBlock T20 (TBS) blocking buffer (37543;
Thermo Scientific) for 30 min, the membrane was incu‐
bated with rabbit anti-cleaved caspase-3 diluted at 1:50,000
at 4°C. After washing with Tris-based buffer (10 mM
Tris-HCl, 150 mM NaCl, 1 mM EDTA, and 0.1% Triton
X-100), the membrane was incubated with HRP-conjugated
goat anti-rabbit IgG at room temperature for 90 min.
Visualization was performed using ECL Prime western
blotting detection reagent (RPN2232; GE Healthcare,
Buckinghamshire, UK), and images were captured with a
CCD camera (ImageQuant LAS4000; GE Healthcare).
For immunofluorescence, cells on coverslips were
fixed with 4% paraformaldehyde in 0.1 M phosphate buffer
(pH 7.4) for 20 min, and then incubated sequentially with
rabbit anti-cleaved caspase-3 diluted at 1:500 and Alexa
488-conjugated donkey anti-rabbit antibody diluted in 0.1%
saponin-PBS.
Antibody to Ki67
HeLa cells were cultured on plastic dishes for immu‐
noblotting or on collagen-coated coverslips for immuno‐
fluorescence for 21 hr at 37°C to almost 40% confluency.
For immunoblotting, cells were scraped in PBS and
centrifuged, and the pellet was homogenized in RIPA
buffer (150 mM NaCl, 0.5% sodium deoxycholate, and 1%
NP-40 in 50 mM Tris-HCl pH 7.5) containing a protease
inhibitor. Samples were denatured by boiling for 10 min,
processed for SDS-PAGE, immunoblotted with rabbit anti-
Ki67 (1:50,000), and visualized with ECL western blotting
detection reagent.
For immunofluorescence, cells on the coverslips were
fixed with 4% paraformaldehyde in 0.1 M phosphate buffer
(pH 7.4) for 20 min, treated with 0.1% Triton X-100 in
PBS for 10 min, and then incubated sequentially with rabbit
anti-Ki67 (1:500) and Alexa 488-conjugated donkey anti-
rabbit antibody.
Antibody to TMEM16A and NKCC1
Normal female ICR mouse parotid glands were
homogenized in PBS containing a protease inhibitor, and
then centrifuged at 800 g for 5 min to remove the nuclei
and tissue debris. The sample was denatured by boiling for
3 min, processed for SDS-PAGE, immunoblotted with
rabbit anti-TMEM16A (1:50,000) or rabbit anti-NKCC1
(1:50,000), and visualized with ECL Prime western blotting
detection reagent.
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Enzyme immunohistochemistry and cell counting
Deparaffinized sections were rehydrated and washed
with PBS. For antigen retrieval, sections were placed in 20
mM Tris-HCl buffer (pH 9.0) and heated in a microwave
oven (MI-77; Azumaya, Tokyo, Japan) for 30 min at 97°C.
After washing with PBS, endogenous peroxidase activity
was blocked with 0.5% H2O2 in methanol for 30 min at
room temperature. After washing with PBS, sections were
sequentially incubated with 1% bovine serum albumin in
PBS to block nonspecific binding of antibodies, and the
primary antibody, rabbit anti-cleaved caspase-3 (1:500) or
rabbit anti-Ki67 (1:500), at 4°C overnight. The secondary
antibody used was HRP-goat anti-rabbit IgG (P0448;
DAKO, Glostrup, Denmark). After washing with PBS, the
DAB reaction was carried out in a solution of DAB
(ImmPACT DAB peroxidase substrate; Vector Laborato‐
ries, Burlingame, CA, USA) for 30 seconds at room tem‐
perature, washed, and then counterstained with Mayer’s
hematoxylin.
Four animals from each group were analyzed. Two
slices from each animal were stained, and specimens
were observed under an Axiophot2 light microscope with
a 40× objective lens. Five areas from each slice were
randomly selected, and images were captured with a DP72
digital camera (Olympus). Cleaved caspase-3-positive aci‐
nar cells or Ki67-positive acinar cells and total acinar cells
within each area were counted. The numbers of positive
acinar cells and total acinar cells from five areas were
finally added, and the ratio of positive to total acinar cells
was obtained for each animal. The mean values of the
positive ratio from four animals from each group were
calculated and statistically analyzed (n = 4).
Immunofluorescence analysis
Paraffin sections of 4 μm thickness were cut and
mounted on adhesive glass slides (Platinum; Matsunami,
Osaka, Japan). Sections were deparaffinized with xylene,
rehydrated, and washed with PBS. For antigen retrieval,
sections were placed in 20 mM Tris-HCl buffer (pH 9.0)
and heated in a microwave oven (MI-77; Azumaya) for 30
min at 97°C. After washing with PBS, sections were incu‐
bated with 5% normal donkey serum-PBS for blocking
nonspecific binding of antibodies, followed by sequential
incubation in primary and secondary antibodies. For
nuclear staining, 4',6-diamidino-2-phenylindole (DAPI)
was added to the mixture of secondary antibodies. Speci‐
mens were mounted with Vectashield mounting medium
(Vector Laboratories), and examined with a BX62 micro‐
scope equipped with Nomarski differential interference-
contrast and epifluorescence optics (Olympus, Tokyo,
Japan). Images were captured using a CoolSNAP K4 CCD
camera (Photometrics, Tucson, AZ, USA) and MetaMorph
software version 6.1 (Molecular Devices, Silicon Valley,
CA, USA).
Histochemical controls
AQP5
Antibody solution was preincubated with an antigen
peptide (10 μg/ml).
Cleaved caspase-3, Ki67, TMEM16A, and NKCC1
Antibody was omitted from primary antibody solution.
Statistical analyses
Data are presented as the mean ± SD. Statistical
analyses were performed using IBM SPSS Statistics 25.
Two-tailed unpaired t-test was used for all analyses. In the
first step, comparison of salivary flow between the IRD
and CTR group was performed to confirm the establish‐
ment of irradiated salivary gland dysfunction mice. When
a significant decrease in the IRD group compared with
the CTR group was confirmed, then comparison between
IRD+Pilo and IRD group was performed to see the effect
of pilocarpine. Similarly, comparison of the positive ratio
of cleaved caspase-3 for apoptosis or Ki67 for cellular pro‐
liferation between the IRD and CTR group was performed
to see whether these are changed by irradiation or not.
Then, comparison between IRD+Pilo and IRD group was
performed to see the effect of pilocarpine. A P value of
<0.05 was considered significant.
III. Results
Stimulation of salivary flow
To evaluate salivary gland function, pilocarpine-
stimulated salivary flow was measured as described previ‐
ously because it is difficult to measure resting salivary flow
in mice [7, 8, 10, 21, 25, 39]. At 30 and 63 days,
pilocarpine-stimulated salivary flow per body weight was
significantly lower in the IRD group than in the CTR group
(Fig. 2A and B), demonstrating the establishment of
irradiation-induced salivary gland dysfunction model mice
as described previously [7, 8, 39]. In response to long-term
administration of pilocarpine, salivary flow was signifi‐
cantly higher in the IRD+Pilo group than in the IRD group
at 30 and 63 days (Fig. 2A and B).
Histological changes
The parotid glands of the IRD group (Fig. 3B) showed
a decrease in acinar cells and an increase in interstitial
spaces and fibers compared with the CTR group (Fig. 3A),
which may have been caused by chronic inflammation,
because many inflammatory cells were evident (Fig. 3B).
No differences in parotid glands were observed between the
IRD (Fig. 3B) and IRD+Pilo (Fig. 3C) groups. No histolog‐
ical changes were observed in the submandibular glands
except for a slight enlargement of acini in the IRD group
(Fig. 3E) compared with those in the CTR group (Fig. 3D).
The submandibular glands did not differ between the IRD
(Fig. 3E) and IRD+Pilo (Fig. 3F) groups.
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Apoptosis and cell proliferation
To clarify the mechanism underlying the beneficial
effect of long-term administration of pilocarpine, we
focused on apoptosis and cellular proliferation and exam‐
ined the changes of cleaved caspase-3 and Ki67. Tissue
slices from four animals from each group were immuno‐
labeled and representative images are shown in Figures 4
and 5. Labeling for cleaved caspase-3 was seen in both
parotid and submandibular glands from all groups, in which
the labeling was chiefly present in acinar cells intracellu‐
larly (Fig. 4). Positive cells in the submandibular gland
seemed to be fewer than those in the parotid gland. Label‐
ing for Ki67 was seen in the nuclei of acinar, ductal, and
interstitial cells of both parotid and submandibular glands
(Fig. 5). We focused on the change of cleaved caspase-3 or
Ki67 in the secretory acini; therefore, ratios of positive
Salivary flow. Pilocarpine-stimulated salivary flow per body weight at 30 days (A) and 63 days (B) after irradiation. Data are expressed as dot and
box plots.
Fig. 2. 
Hematoxylin-eosin staining. Typical images of the parotid (A, B, and C) and submandibular (D, E, and F) glands from each group are shown.
Some of acini and ducts are indicated by “a” and “d”, respectively. Mononuclear infiltrates and increased interstitial fibers in increased interstitial spaces
(asterisks) are indicated by arrows and arrowheads, respectively, in B and C.
Fig. 3. 
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Enzyme immunohistochemistry for cleaved caspase-3. Typical images of the parotid (A, B, and C) and submandibular (D, E, and F) glands from
each group are shown. Arrows indicate positive acinar cells. Arrowheads indicate abnormally enlarged parotid acinar cells with enlarged nuclei.
Fig. 4. 
Enzyme immunohistochemistry for Ki67. Typical images of the parotid (A, B, and C) and submandibular (D, E, and F) glands from each group
are shown. Arrows indicate positive acinar cells. Arrowhead indicates abnormally enlarged parotid acinar cells with enlarged nuclei.
Fig. 5. 
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acinar cells to total acinar cells was calculated and com‐
pared these ratios between the IRD and CTR groups as
described in the materials and methods section and results
are shown in Table 1. The positive cleaved caspase-3 ratio
was significantly higher in the parotid and submandibular
glands of the IRD group than in those of the CTR groups.
Then we compared the positive cleaved caspase-3 ratio in
the IRD+Pilo group with that in the IRD group to see
whether the pilocarpine treatment has a beneficial effect
against apoptosis or not. The positive cleaved caspase-3
ratio in both glands was lower in the IRD+Pilo group than
in the IRD group, although the change was not statistically
significant. The Ki67-positive ratio was significantly higher
in the parotid glands of the IRD group than in those of the
CTR group. When we compared the Ki67-positive ratio in
the parotid glands between the IRD+Pilo and IRD groups,
the ratio was lower in the IRD+Pilo group than in the IRD
group without statistical significance. Similar changes were
seen in Ki67 in the submandibular glands without statistical
significance.
Functional channels and transporter
To determine whether the beneficial effect of pilocar‐
pine was related to functional channels and transporters
involved in salivary fluid secretion, we analyzed the
expression of TMEM16A, AQP5, and NKCC1 by immuno‐
fluorescence microscopy (Figs. 6, 7, and 8, respectively).
TMEM16A was localized to the apical membrane of acinar
cells in both parotid and submandibular glands from the
CTR group (Fig. 6A and D), consistent with a previous
study [34]. AQP5 is mainly localized in the apical mem‐
brane and partially in the basolateral membrane of acinar
cells in both parotid and submandibular glands from the
CTR group (Fig. 7A and D), consistent with previous
studies [28, 29]. NKCC1 seemed to localize to both api‐
cal and basolateral membranes (Fig. 8A and D); therefore,
we performed the double labeling with anti-AQP5 and
Table 1. Positive ratio of cleaved caspase-3 or Ki67 
CTR (n = 4) IRD (n = 4) IRD+Pilo (n = 4)
Cleaved caspase-3
 Parotid gland 0.14 ± 0.13 3.38 ± 1.97 a 1.38 ± 0.56
 Submandibular gland 0.16 ± 0.12 1.62 ± 0.58 b 1.14 ± 0.81
Ki67
 Parotid gland 9.42 ± 9.26 36.2 ± 2.88 c 33.4 ± 10.9
 Submandibular gland 5.65 ± 1.59 16.7 ± 7.78 8.20 ± 1.42
Ratio of positive acinar cells to total acinar cells was calculated as
described in the materials and methods section.
Values (%) are mean ± SD.
Two-tailed unpaired t-test was used to compare IRD with CTR and IRD
+Pilo with IRD.
a P = 0.04 compared with CTR.
b P = 0.01 compared with CTR.
c P = 0.002 compared with CTR.
Immunofluorescence analysis of TMEM16A. Typical fluorescence images of the parotid (A, B, and C) and submandibular (D, E, and F) glands
from each group are shown. Each image was captured under identical conditions. Insets show higher magnification views of a section of individual
images. Arrowheads indicate nonspecific labeling in ducts (see Fig. 12)
Fig. 6. 
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Immunofluorescence analysis of AQP5. Typical fluorescence images of the parotid (A, B, and C) and submandibular (D, E, and F) glands from
each group are shown. Each image was captured under identical conditions. Insets show higher magnification views of a section of individual images.
Fig. 7. 
Immunofluorescence analysis of NKCC1. Typical fluorescence images of the parotid (A, B, and C) and submandibular (D, E, and F) glands from
each group are shown. Each image was captured under identical conditions. Insets show higher magnification views of a section of individual images.
Fig. 8. 
52 Taniguchi et al.
anti-NKCC1 antibodies in the parotid and submandibular
glands from the CTR group to confirm the detailed locali‐
zation (Fig. 9). As a result, NKCC1 was localized mainly
to the basolateral membrane, consistent with a previous
study [14]. Comparison between the CTR and IRD groups
showed no apparent differences both in localization and
expression level for any of these functional proteins (Figs.
6, 7, and 8). Abnormally enlarged parotid acinar cells with
enlarged nuclei, suggesting cellular senescence [19], were
observed in the IRD group (arrowheads in Figs. 4 and 5),
and these functional molecules were detected on the cell
membrane at similar expression levels (Fig. 10). When we
compared the IRD+Pilo with the IRD groups, no apparent
difference both in the localization and expression level was
found in any of these functional proteins (Figs. 6, 7, and 8).
Specificity of antibodies and histochemical controls
The anti-cleaved caspase-3 antibody detected bands
exclusively in apoptosis-induced HeLa cell homogenates.
Two bands were detected (arrows in Fig. 11A), consistent
with a previous study [36], in addition to a strong larger
sized band of unknown origin. Positive immunofluores‐
cence staining was detected in apoptosis-induced HeLa
cells (Fig. 11D and E).
Immunoblot analysis with anti-Ki67 antibody detected
a band in homogenates from proliferating HeLa cells
(arrow in Fig. 11F), consistent with a previous study [38].
Positive immunofluorescence staining was detected in pro‐
liferating HeLa cells (Fig. 11G and H).
Bands were detected by the anti-TMEM16A and
NKCC1 antibodies (arrows in Fig. 11K and L), consistent
with previous studies [13, 34].
Immunofluorescence localization of AQP5 and NKCC1. Double labeling with guinea pig anti-AQP5 (AffGPTM41, green) and rabbit anti-
NKCC1 (magenta) in the CTR parotid gland. AQP5 is localized chiefly to the apical membrane, including intercellular secretory canaliculi, and weakly
to the basolateral membrane, whereas NKCC1 is chiefly localized to the basolateral membrane.
Fig. 9. 
Immunofluorescence localization of TMEM16A, AQP5, and NKCC1 in abnormal cells. Sections from IRD parotid glands were fluorescently
labeled. Fluorescence images of TMEM16A, AQP5, and NKCC1 shown in green are merged with those for DAPI in magenta. Abnormally enlarged
parotid acinar cells with enlarged nuclei are indicated by arrows.
Fig. 10. 
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Specificity of antibodies confirmed by immunoblotting and immunofluorescence. The position of Novex sharp pre-stained protein standards
(kDa) is marked on the right of each blot (A, F, K, and L). Bands near the expected size of each target protein are indicated by arrows in each blot (A,
F, K, and L). A. Immunoblotting of control HeLa and cisplatin-treated HeLa cell homogenates with cleaved caspase-3 antibody. Positive bands are
only seen in cisplatin-treated HeLa cell homogenates. B–E. Immunofluorescence images of control and cisplatin-treated HeLa cells incubated with
cleaved caspase-3 antibody (B and D) and the corresponding Nomarski differential interference-contrast images (C and E). Specific labeling is only
seen in cisplatin-treated, apoptosis-induced, HeLa cells. F. Immunoblotting of HeLa cell homogenates with Ki67 antibody. G–J. Immunofluorescence
images of HeLa cells incubated with (G) or without (I) Ki67 antibody and the corresponding Nomarski differential interference-contrast images (H
and J). K, L. Immunoblotting of mouse parotid gland homogenates with TMEM16A (K) or NKCC1 (L) antibodies.
Fig. 11. 
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A control solution lacking primary antibodies was
used to confirm the specificity of immunohistochemical
staining for cleaved caspase-3 and Ki67 (Fig. 12A and B).
Preincubation of the AQP5 antibody with an immuno‐
genic peptide (10 μg/ml) was performed to confirm the
specificity of immunohistochemical staining; no staining
was observed in acini, whereas nonspecific staining was
observed in ducts (Fig. 12C and D). To confirm the speci‐
ficity of immunofluorescence staining for TMEM16A and
NKCC1, primary antibodies were omitted from the primary
antibody solution; no specific staining was observed in
acini, whereas nonspecific staining was observed in ducts
(Fig. 12E and F).
IV. Discussion
Stimulated salivary flow
To the best of our knowledge, this is the first report
showing that long-term administration of pilocarpine
attenuates the irradiation-induced decrease in salivary flow
in mice for up to 2 months. Pilocarpine treatment for a longer
period may have resulted in a higher salivary flow in these
mice than in untreated irradiated mice. Coppes et al. [7, 8]
and Takakura et al. [39] reported on the efficacy of pre-
treatment with pilocarpine or another muscarinic agonist,
cevimeline. Coppes et al. [8] showed that pilocarpine pre-
treatment improves salivary flow rate in rats receiving 15
Histochemical controls for immunolabeling. A, B. As a control for cleaved caspase-3 and Ki67 staining, sections from IRD parotid (A) and
submandibular (B) glands were incubated with blocking solution instead of primary antibody solution. C, D. As a control for AQP5 staining, sections
were incubated with antibody solution preabsorbed with an antigen peptide. E, F. As a control for TMEM16A and NKCC1 staining, sections were
incubated with blocking solution instead of primary antibody solutions. Arrows indicate nonspecific labeling in ducts.
Fig. 12. 
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Gy irradiation for up to 60 days, whereas it is no longer
effective after 60 days. Takakura et al. [39] showed that
cevimeline administration at 7 days before irradiation and
28 days after irradiation prevents the decrease in salivary
flow, whereas cevimeline administered at 28 days after
irradiation had no effect, suggesting that pre-treatment of
cevimeline is effective for preventing the irradiation-
induced decrease in salivary flow. In the present study,
combined pre- and post-irradiation pilocarpine treatments
were effective for improving salivary flow, although we did
not examine which treatment, pre- or post-irradiation treat‐
ment, would predominantly affect it. The pilocarpine dose
used in the present study, however, was approximately 10-
fold higher than that used clinically; therefore, the effect of
lower doses of pilocarpine needs to be examined in future
studies. In addition, the effect of continuous pilocarpine
administration for a longer period needs to be tested to
determine the duration of efficacy.
Because we measured stimulated salivary flow rather
than resting flow, similar to previous studies [7, 8, 10, 21,
25, 39], a direct comparison of the present results with
those obtained in humans should be performed with cau‐
tion.
Tissue changes including apoptosis and cellular proliferation
We clearly showed the beneficial effect of long-term
administration of pilocarpine. To understand the underlying
mechanism, we examined HE-stained tissues, which
showed decreased acinar areas and increased interstitial tis‐
sue in IRD parotid glands, but no apparent changes in the
submandibular gland. The amount of saliva secreted from
the parotid gland was approximately 30% higher than that
secreted from the submandibular gland in pilocarpine-
stimulated mice [17], indicating that the reduced salivary
flow in IRD mice may be caused by damage to the parotid
gland, despite the lack of apparent damage to the sub‐
mandibular gland. There were no beneficial histological
changes in IRD+Pilo mice compared with IRD mice. We
assessed cleaved caspase-3 as an apoptosis marker and
Ki67 as a cellular proliferation marker. Previous studies
showed an increase in the apoptosis rate at 24 to 48 hr after
low-dose irradiation (2 or 5 Gy) [2, 22] in FVB mice. In the
present study, apoptosis induction was maintained at 63
days after irradiation. Long-term administration of pilocar‐
pine seemed to decrease apoptosis, although the effect was
not statistically significant. Some more studies using a
larger number samples will be required to make sure
whether pilocarpine has an effect in preventing apoptosis or
not, as there was no such report so far. The increased cellu‐
lar proliferation in the parotid glands of the IRD group was
thought to be a compensatory phenomenon for apoptosis.
In addition to apoptosis, enlarged, multinucleated cells
were found in irradiated parotid glands, suggesting the
presence of cellular senescence [19], consistent with a pre‐
vious study showing the presence of senescent cells in irra‐
diated submandibular cells at 8 weeks after irradiation [26].
The possible beneficial effect of pilocarpine on cellular
senescence should be investigated in future studies.
Functional membrane transporter and channels
We examined the effect of pilocarpine on functional
proteins. Takakura et al. [39] showed that the expression
of AQP5, which was downregulated in irradiated mice,
improved in response to cevimeline pre-treatment. There‐
fore, we investigated changes in membrane proteins
involved in salivary secretion, namely, TMEM16A [4, 34]
and NKCC1 [10] in addition to AQP5 [25, 28]. The subcel‐
lular localization and expression levels of these proteins did
not differ between the IRD and CTR groups, as determined
by immunofluorescence. These proteins localized to the
membrane even in abnormally enlarged cells. Takakura et
al. [39] showed that irradiation decreases AQP5 staining
intensity at the apical membrane of submandibular acinar
cells. Although expression levels were not quantified in the
present study, the results suggested that the downregulation
of functional proteins, including AQP5, was not directly
responsible for the decrease in stimulated salivary secretion
in irradiated mice. We thought that the expression levels of
these functional proteins might be increased in the remain‐
ing acinar cells by daily pilocarpine administration in the
IRD+Pilo group, responsible for improving salivary secre‐
tion. The expression levels of these proteins in the remain‐
ing cells, however, did not differ between the IRD and IRD
+Pilo groups. Many factors affect salivary secretion. Fluid
secretion is initiated by acetylcholine, which is released
from parasympathetic postganglionic terminals and binds to
muscarinic type 3 receptor (M3R), triggering an intracellu‐
lar signaling cascade [33]. M3R could be a target of auto‐
antibodies found in Sjögren syndrome patients [3, 18]. The
expression level of M3R in xerostomia caused by irradia‐
tion should be examined in the future.
 
In summary, we investigated the effect of long-term
pilocarpine administration in irradiated mice, and showed
that long-term administration restored the decrease of
stimulated salivary secretion. We also examined potential
underlying factors such as apoptosis, cellular proliferation,
and the expression and localization of TMEM16A,
AQP5, and NKCC1. Pilocarpine may have beneficial ef‐
fects by reducing apoptosis, although additional studies are
required.
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